Citation Impact
Citing Papers
Long-Term Results of Stereotactic Radiosurgery in Secretory Pituitary Adenomas
2009
A Combined Dexamethasone Desmopressin Test as an Early Marker of Postsurgical Recurrence in Cushing’s Disease
2009
Sulfur [ 18 F]Fluoride Exchange Click Chemistry Enabled Ultrafast Late-Stage Radiosynthesis
2021 StandoutNobel
Guidelines for Acromegaly Management: An Update
2009
Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
Long-Term Mortality after Transsphenoidal Surgery and Adjunctive Therapy for Acromegaly1
1998
Astrocytes: biology and pathology
2009 Standout
Why do cancers have high aerobic glycolysis?
2004 Standout
Long-term remission and recurrence rates in Cushing's disease: predictive factors in a single-centre study
2013
Outcome of Cushing's Disease following Transsphenoidal Surgery in a Single Center over 20 Years
2012
Molecular imaging in drug development
2008 Standout
Acromegaly
2006 Standout
Repeat endoscopic transsphenoidal surgery for acromegaly: remission and complications
2013
The Antitumoral Effects of Somatostatin Analog Therapy in Acromegaly
2005
Sequential hormonal changes in 21 patients with recurrent Cushing's disease after successful pituitary surgery
2011
Mortality and Cancer Incidence in Acromegaly: A Retrospective Cohort Study1
1998
The desmopressin test as a predictive factor of outcome after pituitary surgery for Cushing's disease
2004
Guidelines of the Pituitary Society for the diagnosis and management of prolactinomas
2006
Molecular imaging in living subjects: seeing fundamental biological processes in a new light
2003 Standout
Hyperprolactinaemia in 271 women: up to three decades of clinical follow‐up
2005
Reactive astrocytes: cellular and molecular cues to biological function
1997 Standout
The role of porphyrin chemistry in tumor imaging and photodynamic therapy
2010 Standout
Dopamine Resistance of Prolactinomas
2003
Insulin-Like Growth Factors I and II. Peptide, Messenger Ribonucleic Acid and Gene Structures, Serum, and Tissue Concentrations*
1989 Standout
Anatomical and physiological evidence for D1 and D2 dopamine receptor colocalization in neostriatal neurons
2000 StandoutNobel
Pharmacotherapy or Surgery as Primary Treatment for Acromegaly?
2000
Radiotherapy for Pituitary Adenomas
2008
Descending control of pain
2002 Standout
Somatostatin analogues in acromegaly and gastroenteropancreatic neuroendocrine tumours: past, present and future
2016
Stereotactic radiosurgery for Cushing disease: a review
2007
Drug penetration in solid tumours
2006 Standout
Long-Term Predictive Value of Postsurgical Cortisol Concentrations for Cure and Risk of Recurrence in Cushing’s Disease
2003
Nerve Growth Factor in Pituitary Development and Pituitary Tumors
1998
Transsphenoidal Microsurgery for Cushing’s Disease: Initial Outcome and Long-Term Results
2004
Cushing's syndrome
2015 Standout
Phaeochromocytoma
2005 Standout
Molecular defects in the pathogenesis of pituitary tumours
2003
Somatotroph Tumor Progression during Pegvisomant Therapy: A Clinical and Molecular Study
2010
Recurrence of Cushing's Disease Preceded by the Reappearance of ACTH and Cortisol Responses to Desmopressin Test
2004
Pituitary Adenomas with Invasion of the Cavernous Sinus Space
1993 Standout
Brain MRI: Tumor evaluation
2006
Assessment of Disease Activity in Treated Acromegalic Patients Using a Sensitive GH Assay: Should We Achieve Strict Normal GH Levels for a Biochemical Cure?
2002
Long-Term Evaluation of Postoperative Acromegalic Patients in Remission with Previous and Newly Proposed Criteria
2005
Mitogenic effects of nerve growth factor on different cell types in reaggregate cell cultures of immature rat pituitary
1997
Antiproliferative Role of Dopamine: Loss of D2 Receptors Causes Hormonal Dysfunction and Pituitary Hyperplasia
1997
Excess mortality for patients with residual disease following resection of pituitary adenomas
2011
Diagnosis and Treatment of Polycystic Ovary Syndrome: An Endocrine Society Clinical Practice Guideline
2013 Standout
2007 Guidelines for the Management of Arterial Hypertension
2007 Standout
MEDICAL TREATMENT OF PROLACTINOMAS
1999
Glycans in cancer and inflammation — potential for therapeutics and diagnostics
2005 StandoutNobel
Repeat Transsphenoidal Surgery for the Treatment of Remaining or Recurring Pituitary Tumors in Acromegaly
2010
Diagnosis and Treatment of Hyperprolactinemia: An Endocrine Society Clinical Practice Guideline
2011 Standout
Moderate and Severe Traumatic Brain Injury: Epidemiologic, Imaging and Neuropathologic Perspectives
2004
Clinical implications of growth hormone–secreting tumor subtypes
2012
Regulation of cancer cell metabolism
2011 Standout
The Physiology, Signaling, and Pharmacology of Dopamine Receptors
2011 Standout
Aptamers as targeted therapeutics: current potential and challenges
2016 Standout
Nerve growth factor stimulates in vitro invasive capacity of DU145 human prostatic cancer cells
1997
Acromegaly: An Endocrine Society Clinical Practice Guideline
2014 Standout
Diagnosis and Complications of Cushing’s Syndrome: A Consensus Statement
2003 Standout
Transsphenoidal pituitary surgery via the endoscopic technique: results in 35 consecutive patients with Cushing’s disease
2006
Adipokines: inflammation and the pleiotropic role of white adipose tissue
2004 Standout
Efficacy and tolerability of gamma knife radiosurgery in acromegaly: a 10‐year follow‐up study
2009
Molecular imaging of cancer with positron emission tomography
2002
Hypopituitarism following radiotherapy
2008
Effect of protracted treatment with rosiglitazone, a PPARγ agonist, in patients with Cushing's disease
2006
An Akt/β-Arrestin 2/PP2A Signaling Complex Mediates Dopaminergic Neurotransmission and Behavior
2005 StandoutNobel
Identification of a Glioblastoma-Associated Tenascin-C Isoform by a High Affinity Recombinant Antibody
1999 StandoutNobel
Growth-hormone and prolactin excess
1998
ACROMEGALY
1987
Hyperprolactinemia and Prolactinomas
2008
Drug Delivery to the Brain
1997
Spontaneous Spinal Cerebrospinal Fluid Leaks and Intracranial Hypotension
2006 Standout
INVESTIGATION OF THE CRITERIA FOR ASSESSING THE OUTCOME OF TREATMENT IN ACROMEGALY
1987
Comparison of pegvisomant and long-acting octreotide in patients with acromegaly naïve to radiation and medical therapy
2009
Transsphenoidal pituitary surgery in Cushing's disease: can we predict outcome?
2001
Classification of brain tumor type and grade using MRI texture and shape in a machine learning scheme
2009 Standout
Epidemiology, Demographics, and Pathophysiology of Acute Spinal Cord Injury
2001 Standout
Dopaminergic Supersensitivity in G Protein-Coupled Receptor Kinase 6-Deficient Mice
2003 StandoutNobel
Cushing's syndrome
2006 Standout
Nerve growth factor directs differentiation of the bipotential cell line GH-3 into the mammotroph phenotype.
1994
Nerve growth factor: from neurotrophin to neurokine
1996 Nobel
Assessment of long-term remission of acromegaly following surgery
2003
Pathogenesis of pituitary tumors
2011
Withdrawal of Long-Term Cabergoline Therapy for Tumoral and Nontumoral Hyperprolactinemia
2003
Clinical and Biochemical Characteristics of Adrenocorticotropin-Secreting Macroadenomas
2005
Perineural invasion in cancer
2009 Standout
Gamma knife stereotactic radiosurgery for acromegaly
2007
Pathophysiology of the Neuroregulation of Growth Hormone Secretion in Experimental Animals and the Human*
1998 Standout
Approach to the Cushing's Disease Patient With Persistent/Recurrent Hypercortisolism After Pituitary Surgery
2013
Recent Results of Secondary Transnasal Surgery for Residual or Recurring Acromegaly
1998
Therapeutic Nanoparticles for Drug Delivery in Cancer
2008 Standout
Tumor targeting by an aptamer.
2006
Neurotrophins: Roles in Neuronal Development and Function
2001 Standout
Diagnostic Value of the Acid-Labile Subunit in Acromegaly: Evaluation in Comparison with Insulin-Like Growth Factor (IGF) I, and IGF-Binding Protein-1, -2, and -3
2001
Systemic Complications of Acromegaly: Epidemiology, Pathogenesis, and Management
2004 Standout
Characterization of the paradoxical growth hormone inhibitory effect of galanin in acromegaly.
1995
A Consensus on Criteria for Cure of Acromegaly
2010
Growth Hormone-secreting Pituitary Adenomas in Childhood and Adolescence: Features and Results of Transnasal Surgery
1999
LONG‐TERM RESULTS OF TRANSSPHENOIDAL PITUITARY MICROSURGERY IN 60 ACROMEGALIC PATIENTS
1985
Stereotactic Radiosurgery for Acromegaly
2014
Advances in the Treatment of Prolactinomas
2006
Functional Imaging of Endocrine Tumors: Role of Positron Emission Tomography
2004
Prolactin: Structure, Function, and Regulation of Secretion
2000 Standout
Imaging Tri-Fusion Multimodality Reporter Gene Expression in Living Subjects
2004 StandoutNobel
Familial osteosclerosis with abnormalities of the nervous system and meninges
1977
Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United States
2017 Standout
The Chemistry of Neutron Capture Therapy
1998 Standout
Diagnostic Value of the Acid-Labile Subunit in Acromegaly: Evaluation in Comparison with Insulin-Like Growth Factor (IGF) I, and IGF-Binding Protein-1, -2, and -31
2001
Effect of presurgical long-acting octreotide treatment in acromegaly patients with invasive pituitary macroadenomas: a prospective randomized study
2010
DESENSITIZATION OF G PROTEIN–COUPLED RECEPTORS AND NEURONAL FUNCTIONS
2004 StandoutNobel
Boron Neutron Capture Therapy of Cancer: Current Status and Future Prospects
2005 Standout
Erythropoietin crosses the blood–brain barrier to protect against experimental brain injury
2000 Standout
The Cytogenesis and Pathogenesis of Pituitary Adenomas*
1998
Transsphenoidal Surgery for Cushing's Disease
1986
A decade of pituitary microsurgery
1984
Dopamine Receptors: From Structure to Function
1998 Standout
American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the Diagnosis and Treatment of Acromegaly-2011 Update
2011
Works of Massimo Giovanelli being referenced
Persistent Adrenocorticotropin Response to Desmopressin in the Early Postoperative Period Predicts Recurrence of Cushing’s Disease
2009
Long-term results in 62 cases of post-traumatic complete apallic syndrome
1977
Pituitary function before and after transsphenoidal adenomectomy in patients with Cushing's disease
1982
Pre-targeted immunodetection in glioma patients: tumour localization and single-photon emission tomography imaging of [99mTc]PnAO-biotin
1994
Determination of the Proliferation and Apoptotic Index in Adrenocorticotropin-Secreting Pituitary Tumors
2000
Advances in the medical and surgical treatment of pituitary adenomas: The role of long-acting somatostatin analogs
1993
Desmopressin stimulation test before and after pituitary surgery in patients with Cushing's disease
2001
Assessment of Cure and Recurrence After Pituitary Surgery for Cushing's Disease
2001
Surgical Results in Microadenomas
1996
Gamma knife surgery for treatment of residual nonfunctioning pituitary adenomas after surgical debulking
2004
Surgical Treatment of Prolactin-Secreting Pituitary Adenomas: Early Results and Long-Term Outcome
2002
Nerve growth factor and bromocriptine: a sequential therapy for human bromocriptine-resistant prolactinomas
1995
Differentiation of clinically non-functioning pituitary adenomas from meningiomas and craniopharyngiomas by positron emission tomography with [18F]fluoro-ethyl-spiperone
1997
Results of Transsphenoidal Surgery in a Large Series of Patients with Pituitary Adenoma
2005
Results of transsphenoidal surgery in a large series of patients with pituitary adenoma. Neurosurgery 2005;56:1222-1233
2005
Bromocriptine treatment of macroprolactinomas: studies on the time course of tumor shrinkage and morphology
1982
Primary empty sella
1972
Pituitary adenomas in infancy and childhood.
1978
The Role of Stereotactic Radiotherapy in Patients with Growth Hormone-Secreting Pituitary Adenoma
2008
Effects of deep barbiturate coma on acute spinal cord injury in the cat
1984
Criteria of cure and follow-up of central hyperthyroidism due to thyrotropin-secreting pituitary adenomas.
1996
Usefulness of markers of cell proliferation in the management of pituitary adenomas
1998
Clinical use of pre- and postsurgical evaluation of abnormal GH responses in acromegaly
1983
Differentiation of clinically non-functioning pituitary adenomas from meningiomas and craniopharyngiomas by positron emission tomography with [ 18 F]fluoro-ethyl-spiperone
1997
Proliferation Index of Nonfunctioning Pituitary Adenomas: Correlations with Clinical Characteristics and Long-term Follow-up Results
2000
Effects of Octreotide Treatment on the Proliferation and Apoptotic Index of GH-Secreting Pituitary Adenomas
2001
Treatment of acromegaly by transsphenoidal microsurgery
1976
Nerve growth factor controls proliferation and progression of human prolactinoma cell lines through an autocrine mechanism.
1996
Presurgical treatment with somatostatin analogs in patients with acromegaly: effects on the remission and complication rates
2006
Surgical therapy of pituitary adenomas
1996
Enlargement of a prolactin‐secreting pituitary microadenoma during bromocriptine treatment
1982
A comparative evaluation of effectiveness of medical and surgical therapy in patients with macroprolactinoma.
2001
Nerve growth factor suppresses the transforming phenotype of human prolactinomas.
1993